In a patient who experiences stiffness that worsens after exercise, which myotonic disorders should be considered and what is the recommended diagnostic and treatment approach?

Myotonic Conditions with Post-Exercise Stiffness

In patients with stiffness worsening after exercise, consider paramyotonia congenita and sodium channel myotonias first, as these are the primary myotonic disorders where cold exposure and exercise provoke symptoms, distinguishing them from myotonia congenita where exercise typically improves stiffness (the "warm-up phenomenon"). 1

Differential Diagnosis Framework

The myotonic disorders divide into two major categories with distinct post-exercise responses:

Disorders with Exercise-Induced Worsening (Paradoxical Myotonia)

• Paramyotonia congenita: Myotonia worsens with repeated muscle contraction and cold exposure
• Sodium channel myotonias: Stiffness increases with exercise, often triggered by potassium ingestion
• Myotonic dystrophy type 1 (DM1): Progressive distal weakness with myotonia that may worsen with activity 2, 3
• Myotonic dystrophy type 2 (DM2): Proximal muscle involvement, generally milder than DM1 2

Disorders with Exercise-Induced Improvement

• Myotonia congenita (Thomsen and Becker types): Initial stiffness improves with continued activity—the opposite pattern from your question 1

Diagnostic Approach

Clinical Evaluation Specifics

Look for these distinguishing features:

For Paramyotonia Congenita:

• Cold-induced weakness and stiffness
• Eyelid myotonia after forceful closure
• Symptoms worsen progressively with repeated contractions
• Face and hand muscles predominantly affected

For DM1 (most common adult muscular dystrophy):

• Grip myotonia—difficulty releasing hand grip 4
• Distal muscle weakness (finger flexors, foot dorsiflexors)
• Facial weakness with temporal wasting ("hatchet face")
• Ptosis and cataracts
• Cardiac conduction defects
• Frontal balding in males
• Family history (autosomal dominant) 2, 3

For DM2:

• Proximal muscle stiffness and pain
• Neck flexor and finger flexor weakness
• Less severe systemic involvement than DM1 2

Electrodiagnostic Testing

Perform needle EMG looking for:

• Myotonic discharges: waxing-waning amplitude and frequency producing the characteristic "dive bomber" sound 1
• Distribution pattern: widespread myotonia strongly suggests myotonic disorder 1

Exercise testing protocol:

• Test grip strength before and after repetitive exercise
• Cold exposure testing (cooling to 20°C for 20 minutes) differentiates paramyotonia 5
• Long exercise test: 2-5 minutes of maximal voluntary contraction followed by strength measurement 5

Laboratory Workup

Serum CK levels:

• May be mildly elevated (200-500 U/L range) even in asymptomatic phases 4
• Persistently elevated CK in young patients should raise suspicion for DM 4

Genetic testing (definitive diagnosis):

For DM1: CTG trinucleotide repeat expansion in DMPK gene (chromosome 19q13.32)

• Normal: 5-34 repeats
• Premutation (variable alleles): 35-49 repeats—no symptoms but risk to offspring
• Full mutation (fully-variable alleles): ≥50 repeats—causes disease 2
• Use triplet repeat-primed PCR for detection 2

For DM2: CCTG expansion in ZNF9 gene 2

For non-dystrophic myotonias: Sequencing of SCN4A (sodium channel), CLCN1 (chloride channel) genes 1

Critical Pitfalls to Avoid

Do not miss DM1 in patients with isolated CK elevation: Many patients remain undiagnosed for years because mild phenotypes lack obvious muscle weakness. Always ask specifically about grip myotonia—difficulty opening the hand after gripping objects 4. This simple historical feature can prevent years of diagnostic delay.

Recognize life-threatening cardiac involvement: DM1 patients risk sudden death from cardiac conduction defects at any disease stage, not just advanced cases. Order ECG and consider cardiology referral immediately upon diagnosis 3.

Consider congenital DM1 in mothers with mild symptoms: The severe congenital form typically occurs in offspring of affected women who may have minimal symptoms themselves and remain undiagnosed until after delivering an affected child 2.

Treatment Considerations

While the evidence provides limited randomized controlled trial data for myotonic disorder treatment 6, symptomatic management focuses on:

• Mexiletine for myotonia (most commonly used sodium channel blocker)
• Avoid depolarizing neuromuscular blockers (succinylcholine) in surgical settings
• Cardiac monitoring and pacemaker placement when indicated for DM1/DM2
• Genetic counseling given autosomal dominant inheritance 2

The combination of detailed history for post-exercise stiffness pattern, targeted physical examination for grip myotonia, EMG with exercise testing, and genetic confirmation allows accurate classification in nearly all cases 5.